The Food And Drug Administration recently approved a device that provides non-invasive skin cancer screening at the point of care, according to Reuters. DermaSensor, a privately held company, says its spectroscopy technology can use light and artificial intelligence to evaluate cellular and subcellular characteristics to assist clinicians in identifying the presence of skin cancer in suspicious moles or lesions. A study by the Mayo Clinic of more than 1,000 patients showed that the device had …
Read More